ly 181984 has been researched along with tolbutamide in 1 studies
| Studies (ly 181984) | Trials (ly 181984) | Recent Studies (post-2010) (ly 181984) | Studies (tolbutamide) | Trials (tolbutamide) | Recent Studies (post-2010) (tolbutamide) |
|---|---|---|---|---|---|
| 21 | 0 | 0 | 5,368 | 238 | 265 |
| Protein | Taxonomy | ly 181984 (IC50) | tolbutamide (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikins, J; Crowell, TA; Grossman, CS; Harper, RW; Howbert, JJ; Kramer, KE; Poore, GA; Rieder, BJ; Rinzel, SM; Tao, EV | 1 |
1 other study(ies) available for ly 181984 and tolbutamide
| Article | Year |
|---|---|
Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Humans; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Multiple Myeloma; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Sulfonylurea Compounds; Tumor Cells, Cultured | 1990 |